Company intelligence / Profile preview

BenchSci Analytics

Toronto, Ontario, Canada

Ownership: Private
Employees: ~350
Development stage: Other

Overview

BenchSci provides an AI-powered platform (ASCEND) that accelerates preclinical R&D by helping scientists identify, prioritize, and validate targets and experimental designs. It is not a therapeutics development company, so it does not generate clinical results in the traditional sense, but its technology reportedly enables significant productivity and cost savings for major pharmaceutical clients, such as Novartis and Novo Nordisk[4].

Industry: Drug Discovery Services

Partnerships

NovartisNovo Nordisk16 of the world's top 20 pharmaceutical companies

Beyond the preview

Go deeper on BenchSci Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BenchSci Analytics.

Explore the full profile